Re: five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

J Natl Cancer Inst. 1997 Nov 5;89(21):1631-2. doi: 10.1093/jnci/89.21.1631-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Age Factors
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Estrogen Antagonists / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis
  • Middle Aged
  • Receptors, Estrogen / drug effects*
  • Survival Analysis
  • Tamoxifen / administration & dosage*
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Antagonists
  • Receptors, Estrogen
  • Tamoxifen